COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 616
[84] Pospichalova V, Folwarczny M, Harazim D, Rehorova M,
Hanackova M, Vitecek J. Neuroinflammation as the common
cause of neurodegeneration. Neural Regen Res.
2022;17(10):2175-2185.
[85] Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB
dysfunction. Free Radic Res. 2009;43(4):348-364.
[86] Schain M, Kreisl WC. Neuroinflammation in
Neurodegenerative Disorders-a Review. Curr Neurol Neurosci Rep.
2017;17(3):25.
[87] Dong XX, Wang Y, Qin ZH. Molecular mechanisms of
excitotoxicity and their relevance to pathogenesis of
neurodegenerative diseases. Acta Pharmacol Sin.
2009;30(4):379-387.
[88] Kaczor P, Rakus D, Mozrzymas JW. Neuron-astrocyte
interaction enhance GABAergic synaptic transmission in a manner
dependent on key metabolic enzymes. Front Cell Neurosci.
2015;9:120.
[89] Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier
breakdown in Alzheimer disease and other neurodegenerative
disorders. Nat Rev Neurol. 2018;14(3):133-150.
[90] Yamazaki Y, Kanekiyo T. Blood-Brain Barrier Dysfunction and
the Pathogenesis of Alzheimer's Disease. Int J Mol Sci.
2017;18(9):1965.
[91] Obermeier B, Daneman R, Ransohoff RM. Development,
maintenance and disruption of the blood-brain barrier. Nat Med.
2013;19(12):1584-1596.
[92] Ortiz GG, Pacheco-Moisés FP, Macías-Islas MÁ, et al. Role of
the blood-brain barrier in multiple sclerosis. Arch Med Res.
2014;45(8):687-697.
616
